Briacell TherapeuticsBCTX

13F holders, Q2 2024 (June 30)
20holders +1
4new positions
2sold out
2famous investors
$1.16avg. 13F price*

At the end of Q2 2024, 20 institutions reported holding Briacell Therapeutics Corp. (BCTX) in their 13F filings, up 1 from Q1 2024. 4 opened new positions and 2 sold out. The largest holders were Redmond Asset Management, LLC ($131K), Bank of Montreal ($72K) and Onyx Bridge Wealth Group LLC ($57K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Briacell Therapeutics Corp.
CUSIP
107930109
Latest filing quarter
Q4 2024

History

Number of 13F holders

0102030 Q1 2024: 19Q1 2024Q2 2024: 20Q2 2024Q3 2024: 22Q3 2024Q4 2024: 26Q4 2024

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions4$41K
Exits2$347K

All 13F filers, Q1 2024 → Q2 2024: 42,340 shares bought and 247,434 shares sold, net −205,094 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

Redmond Asset Management, LLC 0.04% Reduce -13.3% 115,346 $131K
Bank of Montreal 0.00% Reduce -58.0% 56,341 $72K
Onyx Bridge Wealth Group LLC 0.01% No change 50,000 $57K
Summit Trail Advisors, LLC 0.00% No change 35,000 $40K
Bank of America Corp. 0.00% Reduce -1.1% 17,799 $20K
Renaissance Technologies 0.00% Add +22.9% 15,000 $17K
HighTower Advisors, LLC 0.00% Add +1.9% 14,728 $16K
XTX Topco Ltd 0.00% New 12,364 $14K
Susquehanna International Group, LLP 0.00% No change 12,357 $14K
LPL Financial LLC 0.00% New 11,558 $13K
Group One Trading LLC 0.00% New 10,894 $12K
Concord Wealth Partners 0.00% Reduce -4.4% 10,301 $12K
Citadel Advisors 0.00% Add +50.0% 9,641 $11K
National Bank of Canada 0.00% No change 7,500 $8K
Royal Bank of Canada 0.00% Add +6.4% 3,832 $4K
TD Waterhouse Canada Inc. 0.00% Reduce -71.4% 3,450 $4K
Morgan Stanley 0.00% Reduce -88.8% 2,658 $3K
Osaic Holdings, Inc. 0.00% Reduce -0.6% 1,026 $1K
HHM Wealth Advisors, LLC 0.00% New 1,000 $1K
Tower Research Capital LLC (TRC) 0.00% Reduce -32.9% 528 $602

"% of holder's portfolio" is BCTX's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.